Neutral
Sanara MedTech Inc. ( SMTI ) Reports Q2 Loss, Tops Revenue Estimates
Sanara MedTech (SMTI) delivered earnings and revenue surprises of +30.30% and +1.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?